Test Price
2,800 AEDโ Home Collection Available
SDHD Gene Paraganglioma Type 1 Genetic Test in Dubai, UAE โ NGS Sequencing | 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Next-Generation Sequencing. Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM to 11 PM daily). Clinical Guidance: Complimentary telephonic post-test genetic counseling coordination for result interpretation. Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced next-generation sequencing (NGS) test comprehensively analyzes the entire SDHD gene to detect germline mutations responsible for hereditary paraganglioma type 1 syndrome, with or without sensorineural deafness. It empowers oncologists and genetic counselors to stratify cancer risk, guide surveillance, and inform family screening.
| Feature | Our SDHD NGS Test | Standard Sanger Sequencing / Other Labs |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) โ Full gene, all exons, splice sites, deep coverage | Targeted mutation analysis or low-coverage single-exon sequencing |
| Mutation Detection Rate | >99.9% sensitivity for known & novel variants | Only preselected hotspots; misses rare mutations |
| Turnaround Time | 3 โ 4 Weeks | Often 4 โ 8 Weeks |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), DHA-compliant facility license 1143 | Variable; many lack UAE-specific ISO and DHA recognition |
| Post-Test Support | Complimentary telephonic clinical guidance & genetic counseling coordination | Often limited to report only |
| Price | 2800 AED | May vary; often higher for full gene analysis abroad |
Physician Insight & Safety Protocols
โThis genetic test identifies SDHD mutations that confer a hereditary predisposition to paraganglioma and pheochromocytoma syndromes. However, a positive result indicates increased lifetime risk, not certainty of tumor development. All results must be correlated with clinical presentation, family history, and imaging studies. Genetic counseling is essential before and after testing to guide appropriate follow-up and family cascade screening.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Clinical Caution
Do not alter or discontinue any prescribed medications based solely on genetic test results without consulting your treating physician. Use this information to complement, not replace, clinical judgment.
Exclusion Criteria & Safety Red Flags
- Individuals under 18 years require legal guardian consent and mandatory pre- and post-test genetic counseling per UAE Federal Law and DHA regulations.
- Testing should be guided by a specialist if there is no clinical suspicion or family history of paraganglioma/pheochromocytoma.
- Red flags requiring immediate medical attention: sudden severe headache, palpitations, episodic hypertension, tinnitus, or unexplained syncope.
- If you experience any of these symptoms, seek emergency care; do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the SDHD gene test and who should consider it?
This DNA test identifies mutations in the SDHD gene linked to hereditary paraganglioma-pheochromocytoma syndrome, guiding personalized cancer screening for you and your family. Candidates include individuals with a personal or family history of paragangliomas, pheochromocytomas, early-onset deafness, or those with a known familial SDHD mutation seeking peace of mind.
2. How is the sample collected and what is the turnaround time?
A simple blood draw is sufficient; results are reported in 3 to 4 weeks. Our VIP mobile phlebotomy service ensures safe, cold-chain transport at your convenience between 8 AM and 11 PM, and you can track your sample status via WhatsApp.
3. What preparation is required before taking this genetic test?
A genetic counseling session to construct a detailed pedigree chart and provide clinical history is mandatory; no fasting or special diet is required. Please share any relevant medical records, imaging reports, or prior genetic results with our team to ensure accurate interpretation.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE adheres strictly to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data handling, storage, and transmission comply with the highest security standards. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your results are shared only with you and your designated healthcare provider upon explicit written authorization.
Clinical & Logistical Metadata
| Test Name | SDHD Gene Paraganglioma Type 1 Genetic Test (NGS) |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 โ 4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Cold-Chain Home Collection available daily 8 AM โ 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | D44.7 |
| LOINC Code | 94483-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians